pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·1h ago·1 min read
save

Five major drugmakers cooperate with House investigation of Chinese military hospital trials

Sep 16, 2026·read at Endpoints ↗RegulatoryNeutral

Rep. John Moolenaar, a Republican from Michigan, announced that five large pharmaceutical companies are working with a congressional probe into clinical trials conducted at Chinese military hospitals.

The companies have agreed to provide information and assistance to lawmakers as the investigation seeks to understand how the trials were run and whether any regulatory standards were breached.

The probe reflects growing scrutiny of overseas clinical research practices, but the companies’ cooperation signals a willingness to address any concerns raised by U.S. officials.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “Drugmakers cooperate with House probe of China trial sites”

read at Endpoints ↗
102 words · retrieved 1h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
LEADINGOVERSEASSionna Therapeutics, Inc.
topics
ALS

related stories

  • Sep 4Ionis’ ‘breakthrough’ Alexander disease approval establishes pillar of rare disease pipelineFierce Biotech
  • Sep 3FDA approves Ionis’ antisense drug as first targeted therapy for Alexander diseaseBioSpace
  • Aug 25Amgen, academic centers weigh new FDA pilot to speed early drug trialsEndpoints
  • Aug 25J&J’s Imaavy wins label expansion; Two approvals in JapanEndpoints
  • Aug 18Rebounding biotech funds expected to spur CDMO growth within yearBioSpace